These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7977509)

  • 21. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cryptococcus neoformans meningitis in a patient with hairy cell leukemia.
    Dinçol G; Kahraman R
    Am J Hematol; 2006 May; 81(5):387. PubMed ID: 16628737
    [No Abstract]   [Full Text] [Related]  

  • 23. [Progress in the treatment of hairy cell leukemia. Subcutaneous administration of 2-chloro-deoxy-adenosine for 7 days].
    Heldal D; Tjønnfjord GE; Evensen SA; Juliusson G
    Tidsskr Nor Laegeforen; 1994 Mar; 114(7):800-3. PubMed ID: 7912011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia.
    Forconi F; Toraldo F; Sozzi E; Amato T; Raspadori D; Lauria F
    Leuk Lymphoma; 2007 Dec; 48(12):2441-3. PubMed ID: 18067021
    [No Abstract]   [Full Text] [Related]  

  • 25. Hairy Cell Leukemia and cutaneous involvement.
    Ergene U; Ozbalcı D; Işisağ A
    Transfus Apher Sci; 2012 Apr; 46(2):231-2. PubMed ID: 22370038
    [No Abstract]   [Full Text] [Related]  

  • 26. Alternative methods of cladribine administration.
    Lauria F; Cencini E; Forconi F
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():34-7. PubMed ID: 21504286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hairy cell leukemia-variant with cladribine.
    Tetreault SA; Robbins BA; Saven A
    Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypersensitivity reactions to multiple drugs during the course of hairy cell leukemia treated with 2-chlorodeoxyadenosine].
    Kokunai A; Azusawa H; Murota H; Ohhata C; Katayama I; Murata S; Tadokoro S
    Arerugi; 2006 Jun; 55(6):662-6. PubMed ID: 16883103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hairy cell leukemia treated with cladribine].
    Ghanima W; Heldal D; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1094-7. PubMed ID: 12043051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature.
    Setoodeh R; Zhang L
    Leuk Lymphoma; 2012 Apr; 53(4):736-8. PubMed ID: 21980957
    [No Abstract]   [Full Text] [Related]  

  • 31. Lack of toxicity in a cladribine extravasation.
    Mateu-de Antonio J; Acuña-Reina L; Pons JC; Buisán MJ
    Ann Pharmacother; 1999; 33(7-8):873. PubMed ID: 10466922
    [No Abstract]   [Full Text] [Related]  

  • 32. The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Koczwara B; Spangenthal E; Bernstein SH
    Leuk Lymphoma; 1997 Jul; 26(3-4):413-5. PubMed ID: 9322907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subcutaneous therapy of hairy cell leukemia with 2-chlorodeoxyadenosine].
    Nielsen OJ; Hippe E; Priø TK; Juliusson G
    Ugeskr Laeger; 1994 Apr; 156(16):2407-9. PubMed ID: 7912015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol.
    Espinosa Lara P; Quirós Redondo V; Aguado Lobo M; Jiménez-Reyes J
    Ann Hematol; 2017 Jul; 96(7):1209-1210. PubMed ID: 28391438
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow granulomas in hairy cell leukaemia following 2-chlorodeoxyadenosine therapy.
    Franco V; Florena AM; Quintini G; Musso M
    Histopathology; 1994 Mar; 24(3):271-3. PubMed ID: 7911119
    [No Abstract]   [Full Text] [Related]  

  • 36. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma.
    Beksaç M; Arat M; Idilman R
    Cancer; 1999 Jan; 85(1):242-3. PubMed ID: 9921999
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O
    Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological examination of the extrabulbar segment of the optic nerve in experimental animals after administration of Cladribine.
    Kwietniewska M; Stelmasiak Z; Sekita-Krzak J; Visconti J; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):222-6. PubMed ID: 12898843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness?
    Juliusson G
    Am J Hematol; 1996 Sep; 53(1):49. PubMed ID: 8813099
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hairy cell leukemia therapy by cladribine].
    Ogura M
    Nihon Rinsho; 2004 Jul; 62(7):1337-42. PubMed ID: 15283153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.